Mega Lifesciences Public Co. Ltd. (MEGA) Financial Statements

Mega Lifesciences Public Co. Ltd. Financial Overview

Mega Lifesciences Public Co. Ltd.'s market cap is currently THB30.73B. The company's EPS TTM is THB2.51; its P/E ratio is 14.14; and it has a dividend yield of 4.68%. Mega Lifesciences Public Co. Ltd. is estimated to report earnings on November 16, 2026, and the estimated EPS forecast is THB0.64. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	THB 14.15B	THB 15.34B	THB 15.68B	THB 15.69B	THB 14.14B
Gross Profit	THB 7.27B	THB 7.75B	THB 6.98B	THB 7.04B	THB 5.91B
Operating Income	THB 2.90B	THB 3.37B	THB 2.90B	THB 2.72B	THB 2.18B
EBITDA	THB 2.74B	THB 2.67B	THB 2.58B	THB 2.90B	THB 2.58B
Net Income	THB 1.91B	THB 2.01B	THB 1.99B	THB 2.24B	THB 1.95B
Balance Sheet
Cash & Short-Term Investments	THB 4.64B	THB 3.81B	THB 2.71B	THB 2.79B	THB 2.53B
Total Assets	THB 16.00B	THB 14.21B	THB 14.52B	THB 14.65B	THB 13.27B
Total Debt	THB 683.54M	THB 491.24M	THB 251.84M	THB 420.87M	THB 356.33M
Net Debt	THB -3.60B	THB -2.97B	THB -2.10B	THB -2.03B	THB -1.84B
Total Liabilities	THB 5.78B	THB 4.33B	THB 5.22B	THB 5.87B	THB 5.25B
Stockholders' Equity	THB 10.22B	THB 9.88B	THB 9.30B	THB 8.78B	THB 8.00B
Cash Flow
Free Cash Flow	THB 2.14B	THB 2.14B	THB 1.63B	THB 1.68B	THB 2.57B
Operating Cash Flow	THB 2.81B	THB 2.40B	THB 1.93B	THB 2.00B	THB 2.73B
Investing Cash Flow	THB -669.11M	THB 1.45M	THB -250.01M	THB -280.82M	THB -264.68M
Financing Cash Flow	THB -1.25B	THB -1.28B	THB -1.68B	THB -1.43B	THB -1.31B

Currency in THB

Mega Lifesciences Public Co. Ltd. Earnings and Revenue History

Income Statement >

Mega Lifesciences Public Co. Ltd. Liabilities to Assets

Balance Sheet >

Mega Lifesciences Public Co. Ltd. Cash Flow

Cash Flow >

Mega Lifesciences Public Co. Ltd. Forecast EPS vs Actual EPS

Earnings >

Mega Lifesciences Public Co. Ltd. financials statements